{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:21:22Z","timestamp":1773296482121,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/jps.22494","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T14:53:01Z","timestamp":1296485581000},"page":"2693-2702","source":"Crossref","is-referenced-by-count":13,"title":["Mannitol Delivery by Vibrating Mesh Nebulisation for Enhancing Mucociliary Clearance"],"prefix":"10.1016","volume":"100","author":[{"given":"John Gar Yan","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip Chi Lip","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak-Kim","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1002\/jps.22494_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.coph.2007.01.004","article-title":"The epithelium as a target for therapy in cystic fibrosis","volume":"7","author":"Thelin","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"10.1002\/jps.22494_bb0010","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/13543784.16.7.1121","article-title":"Inhaled mannitol in cystic fibrosis","volume":"16","author":"Wills","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1002\/jps.22494_bb0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.coph.2010.04.003","article-title":"Osmolytes and ion transport modulators: New strategies for airway surface rehydration","volume":"10","author":"Goralski","year":"2010","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1002\/jps.22494_bb0020","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.159.6.9809074","article-title":"Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis","volume":"159","author":"Daviskas","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1002\/jps.22494_bb0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1378\/chest.119.2.414","article-title":"The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis","volume":"119","author":"Daviskas","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1002\/jps.22494_bb0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1183\/09031936.00119707","article-title":"Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis","volume":"31","author":"Daviskas","year":"2008","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1002\/jps.22494_bb0035","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.rmed.2010.05.019","article-title":"Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction","volume":"104","author":"Daviskas","year":"2010","journal-title":"Respir Med"},{"issue":"4","key":"10.1002\/jps.22494_bb0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.09-2017","article-title":"Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis","volume":"137","author":"Daviskas","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1002\/jps.22494_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prrv.2007.02.008","article-title":"Other mucoactive agents for cystic fibrosis","volume":"8","author":"Bye","year":"2007","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"10.1002\/jps.22494_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcf.2009.04.005","article-title":"Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus","volume":"8","author":"Heijerman","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1002\/jps.22494_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00441-007-0482-7","article-title":"Effects of hyperosmotic stress on cultured airway epithelial cells","volume":"330","author":"Nilsson","year":"2007","journal-title":"Cell Tissue Res"},{"issue":"Suppl 1","key":"10.1002\/jps.22494_bb0060","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/j.prrv.2006.04.198","article-title":"The pharmacologic approach to airway clearance: Mucoactive agents","volume":"7","author":"Rubin","year":"2006","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1002\/jps.22494_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001506.pub3","article-title":"Nebulised hypertonic saline for cystic fibrosis","author":"Wark","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1002\/jps.22494_bb0070","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/thx.52.10.900","article-title":"Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis","volume":"52","author":"Robinson","year":"1997","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/jps.22494_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med"},{"issue":"35","key":"10.1002\/jps.22494_bb0080","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1074\/jbc.M604332200","article-title":"Hypertonic saline therapy in cystic fibrosis","volume":"281","author":"Levin","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1002\/jps.22494_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1569-1993(01)00009-1","article-title":"Hypertonic saline and recombinant human DNase: A randomised cross-over pilot study in patients with cystic fibrosis","volume":"1","author":"Ballmann","year":"2002","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1002\/jps.22494_bb0090","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1399-3003.1999.14c30.x","article-title":"The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: A pilot study","volume":"14","author":"Robinson","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.22494_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/thx.2009.116970","article-title":"Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: A randomised trial","volume":"65","author":"Minasian","year":"2010","journal-title":"Thorax"},{"key":"10.1002\/jps.22494_bb0100","first-page":"A2338","article-title":"Phase III study of inhaled dry powder mannitol (bronchitol) in cystic fibrosis results from the 6month open label phase","volume":"181","author":"Bilton","year":"2010","journal-title":"Am J Respir Crit Care Med (1_Meeting Abstracts)"},{"issue":"2","key":"10.1002\/jps.22494_bb0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/156720108783954815","article-title":"Advanced nebulizer designs employing vibrating mesh\/aperture plate technologies for aerosol generation","volume":"5","author":"Waldrep","year":"2008","journal-title":"Curr Drug Deliv"},{"issue":"9","key":"10.1002\/jps.22494_bb0110","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/03639040802144211","article-title":"Current therapies and technological advances in aqueous aerosol drug delivery","volume":"34","author":"Watts","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1002\/jps.22494_bb0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/17425247.3.5.693","article-title":"New advances in aerosolised drug delivery: Vibrating membrane nebuliser technology","volume":"3","author":"Lass","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1002\/jps.22494_bb0120","first-page":"699","article-title":"Aerosol delivery devices in the treatment of asthma","volume":"53","author":"Hess","year":"2008","journal-title":"Respir Care"},{"key":"10.1002\/jps.22494_bb0125","series-title":"Advanced drug formulation design to optimize therapeutic outcomes","first-page":"1","article-title":"Advances in pulmonary delivery","author":"Young","year":"2008"},{"issue":"Suppl 29","key":"10.1002\/jps.22494_bb0130","first-page":"292","article-title":"Tolerability of hypertonic saline when delivered rapidly via the eFlow rapid nebulizer in subjects with cystic fibrosis","volume":"41","author":"Elkins","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1002\/jps.22494_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jps.22231","article-title":"A technical feasibility study of dornase alfa delivery with eflow\u00ae vibrating membrane nebulizers: Aerosol characteristics and physicochemical stability","volume":"100","author":"Scherer","year":"2011","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.22494_bb0140","first-page":"174","article-title":"Performance comparison of nebulizer designs: Constant-output, breath-enhanced, and dosimetric","volume":"49","author":"Rau","year":"2004","journal-title":"Respir Care"},{"issue":"3","key":"10.1002\/jps.22494_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/S0892-1997(03)00078-X","article-title":"An evaluation of the effects of three laryngeal lubricants on phonation threshold pressure (PTP)","volume":"17","author":"Roy","year":"2003","journal-title":"J Voice"},{"key":"10.1002\/jps.22494_bb0150","series-title":"Perry's chemical engineers' handbook","author":"Perry","year":"1997"},{"key":"10.1002\/jps.22494_bb0155","series-title":"Carbohydrate biotechnology protocols","first-page":"261","article-title":"Production of mannitol by fermentation","author":"Soetaert","year":"1999"},{"issue":"2","key":"10.1002\/jps.22494_bb0160","first-page":"280","article-title":"Preparations for nebulization: Characterization, general chapter 2.9.44","volume":"18","year":"2006","journal-title":"Pharmeuropa"},{"issue":"4","key":"10.1002\/jps.22494_bb0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/jam.2006.19.409","article-title":"Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers","volume":"19","author":"Mitchell","year":"2006","journal-title":"J Aerosol Med"},{"issue":"5","key":"10.1002\/jps.22494_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/jamp.2009.0805","article-title":"Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer","volume":"23","author":"Rao","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"10.1002\/jps.22494_bb0175","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jam.2005.18.311","article-title":"Comparison of cascade impaction and laser diffraction for particle size distribution measurements","volume":"18","author":"Ziegler","year":"2005","journal-title":"J Aerosol Med"},{"issue":"2","key":"10.1002\/jps.22494_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jam.2007.0556","article-title":"Determination of nebulizer droplet size distribution: A method based on impactor refrigeration","volume":"20","author":"Berg","year":"2007","journal-title":"J Aerosol Med"},{"issue":"1","key":"10.1002\/jps.22494_bb0185","first-page":"27","article-title":"Cooling the NGI\u2014An approach to size a nebulised aerosol more accurately","volume":"2008","author":"Dennis","year":"2008","journal-title":"Pharmeur Sci Notes"},{"issue":"1","key":"10.1002\/jps.22494_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-5173(94)00255-4","article-title":"The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers","volume":"115","author":"Clark","year":"1995","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1002\/jps.22494_bb0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-5173(02)00526-4","article-title":"Characterization of inhalation aerosols: A critical evaluation of cascade impactor analysis and laser diffraction technique","volume":"249","author":"de Boer","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22494_bb0200","series-title":"Respiratory drug delivery","first-page":"745","article-title":"Correlation of laser diffraction and cascade impaction data for aqueous solutions aerosolized by the eFlow\u00ae electronic nebulizer (poster)","author":"Keller","year":"2006"},{"issue":"2","key":"10.1002\/jps.22494_bb0205","first-page":"49","article-title":"Laser diffractometry and cascade impaction for nebulizer product characterization","volume":"2006","author":"Mitchell","year":"2006","journal-title":"Pharmeur Sci Notes"},{"issue":"1","key":"10.1002\/jps.22494_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/08942680152007954","article-title":"Validation of laser diffraction method as a substitute for cascade impaction in the European project for a nebulizer standard","volume":"14","author":"Vecellio None","year":"2001","journal-title":"J Aerosol Med"},{"issue":"4","key":"10.1002\/jps.22494_bb0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/jam.2000.13.303","article-title":"Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor","volume":"13","author":"Kwong","year":"2000","journal-title":"J Aerosol Med"},{"issue":"3","key":"10.1002\/jps.22494_bb0220","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijmultiphaseflow.2008.11.001","article-title":"Light multiple scattering correction of laser-diffraction spray drop-size distribution measurements","volume":"35","author":"Dumouchel","year":"2009","journal-title":"Int J Multiphas Flow"},{"key":"10.1002\/jps.22494_bb0225","series-title":"Respiratory therapy equipment\u2013Part 1: Nebulizing systems and their components Annex DD Method for characterization of nebulizers with respect to droplet size using laser diffraction","article-title":"CEN-Nebulizer Standard EN 13544\u20131","year":"2001"},{"issue":"12","key":"10.1002\/jps.22494_bb0230","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jaerosci.2010.08.003","article-title":"Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization in air and a helium\u2013oxygen mixture","volume":"41","author":"Martin","year":"2010","journal-title":"J Aerosol Sci"},{"issue":"3","key":"10.1002\/jps.22494_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/jamp.2009.0795","article-title":"Electrostatic charge characteristics of jet nebulized aerosols","volume":"23","author":"Kwok","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1002\/jps.22494_bb0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/jamp.2008.0736","article-title":"Evolution of evaporative understanding within nebulizer standards","volume":"22","author":"Dennis","year":"2009","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"10.1002\/jps.22494_bb0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/jam.2004.17.335","article-title":"Next generation pharmaceutical impactor: A new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15L\/min","volume":"17","author":"Marple","year":"2004","journal-title":"J Aerosol Med"},{"issue":"6","key":"10.1002\/jps.22494_bb0250","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1365-2621.1985.tb10560.x","article-title":"Liquid chromatographic analysis of sugars and mannitol in cabbage and fermenting sauerkraut","volume":"50","author":"Hughes","year":"1985","journal-title":"J Food Sci"},{"issue":"7","key":"10.1002\/jps.22494_bb0255","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1211\/jpp.58.7.0002","article-title":"Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers","volume":"58","author":"Elhissi","year":"2006","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20132","key":"10.1002\/jps.22494_bb0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2007.02.035","article-title":"The influence of fluid physicochemical properties on vibrating-mesh nebulization","volume":"339","author":"Ghazanfari","year":"2007","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1002\/jps.22494_bb0265","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/jam.2007.0622","article-title":"Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer","volume":"20","author":"Zhang","year":"2007","journal-title":"J Aerosol Med"},{"issue":"5","key":"10.1002\/jps.22494_bb0270","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0928-0987(03)00148-9","article-title":"Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers","volume":"19","author":"Steckel","year":"2003","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1002\/jps.22494_bb0275","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1023\/A:1016205520044","article-title":"Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers","volume":"12","author":"McCallion","year":"1995","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1002\/jps.22494_bb0280","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2009.10.012","article-title":"Surface active drugs significantly alter the drug output rate from medical nebulizers","volume":"384","author":"Arzhavitina","year":"2010","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.22494_bb0285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.foodchem.2009.03.075","article-title":"Effect of conformation and water interactions of sucrose, maltitol, mannitol and xylitol on their metastable zone width and ease of nucleation","volume":"122","author":"Bensouissi","year":"2010","journal-title":"Food Chem"},{"issue":"6\u201310","key":"10.1002\/jps.22494_bb0290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.elstat.2005.03.048","article-title":"Comparison of conduction and induction charging in liquid spraying","volume":"63","author":"Zhao","year":"2005","journal-title":"J Electrostat"},{"issue":"9","key":"10.1002\/jps.22494_bb0295","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1021\/je9010486","article-title":"Densities and viscosities of sugar alcohol aqueous solutions","volume":"55","author":"Zhu","year":"2010","journal-title":"J Chem Eng Data"},{"issue":"3","key":"10.1002\/jps.22494_bb0300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1208\/ps040313","article-title":"Aerosolization of lipoplexes using AERx\u00ae pulmonary delivery system","volume":"4","author":"Deshpande","year":"2002","journal-title":"AAPS J"},{"issue":"3","key":"10.1002\/jps.22494_bb0305","first-page":"405","article-title":"Electrostatic charge in AERX\u2122 aerosols (abstract)","volume":"14","author":"Rosell","year":"2001","journal-title":"J. Aerosol Med"},{"issue":"6","key":"10.1002\/jps.22494_bb0310","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4187\/002013209790983250","article-title":"New aerosol delivery devices for cystic fibrosis","volume":"54","author":"Kesser","year":"2009","journal-title":"Respir Care"},{"issue":"3","key":"10.1002\/jps.22494_bb0315","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/jamp.2008.0712","article-title":"Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6months use by CF patients","volume":"22","author":"Rottier","year":"2009","journal-title":"Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"10.1002\/jps.22494_bb0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1183\/18106838.0203.252","article-title":"The mesh nebuliser: a recent technical innovation for aerosol delivery","volume":"2","author":"Vecellio","year":"2006","journal-title":"Breathe"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T03:07:59Z","timestamp":1559963279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915320578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022354915320578"],"URL":"https:\/\/doi.org\/10.1002\/jps.22494","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}